TY - JOUR
T1 - High Burden of Bloodstream Infections Associated with Antimicrobial Resistance and Mortality in the Neonatal Intensive Care Unit in Pune, India
AU - Johnson, Julia
AU - Robinson, Matthew L.
AU - Rajput, Uday C.
AU - Valvi, Chhaya
AU - Kinikar, Aarti
AU - Parikh, Tushar B.
AU - Vaidya, Umesh
AU - Malwade, Sudhir
AU - Agarkhedkar, Sharad
AU - Randive, Bharat
AU - Kadam, Abhay
AU - Smith, Rachel M.
AU - Westercamp, Matthew
AU - Mave, Vidya
AU - Gupta, Amita
AU - Milstone, Aaron M.
AU - Manabe, Yukari C.
N1 - Funding Information:
This work was supported by the US Centers for Disease Control and Prevention (Safe Healthcare, Epidemiology, and Prevention Research Development Program Domain 7, contract 200-2016-91781) and the National Institutes of Health (UM1AI104681 to M. L. R. and K24AI141580 to A. M. M.).
Publisher Copyright:
© 2020 The Author(s). Published by Oxford University Press for the Infectious Diseases Society of America.
PY - 2021/7/15
Y1 - 2021/7/15
N2 - Background: Antimicrobial resistance (AMR) is a growing threat to newborns in low- and middle-income countries (LMIC). Methods: We performed a prospective cohort study in 3 tertiary neonatal intensive care units (NICUs) in Pune, India, to describe the epidemiology of neonatal bloodstream infections (BSIs). All neonates admitted to the NICU were enrolled. The primary outcome was BSI, defined as positive blood culture. Early-onset BSI was defined as BSI on day of life (DOL) 0-2 and late-onset BSI on DOL 3 or later. Results: From 1 May 2017 until 30 April 2018, 4073 neonates were enrolled. Among at-risk neonates, 55 (1.6%) developed early-onset BSI and 176 (5.5%) developed late-onset BSI. The majority of BSIs were caused by gram-negative bacteria (GNB; 58%); among GNB, 61 (45%) were resistant to carbapenems. Klebsiella spp. (n = 53, 23%) were the most common cause of BSI. Compared with neonates without BSI, all-cause mortality was higher among neonates with early-onset BSI (31% vs 10%, P < .001) and late-onset BSI (24% vs 7%, P < .001). Non-low-birth-weight neonates with late-onset BSI had the greatest excess in mortality (22% vs 3%, P < .001). Conclusions: In our cohort, neonatal BSIs were most commonly caused by GNB, with a high prevalence of AMR, and were associated with high mortality, even in term neonates. Effective interventions are urgently needed to reduce the burden of BSI and death due to AMR GNB in hospitalized neonates in LMIC.
AB - Background: Antimicrobial resistance (AMR) is a growing threat to newborns in low- and middle-income countries (LMIC). Methods: We performed a prospective cohort study in 3 tertiary neonatal intensive care units (NICUs) in Pune, India, to describe the epidemiology of neonatal bloodstream infections (BSIs). All neonates admitted to the NICU were enrolled. The primary outcome was BSI, defined as positive blood culture. Early-onset BSI was defined as BSI on day of life (DOL) 0-2 and late-onset BSI on DOL 3 or later. Results: From 1 May 2017 until 30 April 2018, 4073 neonates were enrolled. Among at-risk neonates, 55 (1.6%) developed early-onset BSI and 176 (5.5%) developed late-onset BSI. The majority of BSIs were caused by gram-negative bacteria (GNB; 58%); among GNB, 61 (45%) were resistant to carbapenems. Klebsiella spp. (n = 53, 23%) were the most common cause of BSI. Compared with neonates without BSI, all-cause mortality was higher among neonates with early-onset BSI (31% vs 10%, P < .001) and late-onset BSI (24% vs 7%, P < .001). Non-low-birth-weight neonates with late-onset BSI had the greatest excess in mortality (22% vs 3%, P < .001). Conclusions: In our cohort, neonatal BSIs were most commonly caused by GNB, with a high prevalence of AMR, and were associated with high mortality, even in term neonates. Effective interventions are urgently needed to reduce the burden of BSI and death due to AMR GNB in hospitalized neonates in LMIC.
KW - antimicrobial resistance
KW - low- and middle-income countries
KW - neonatal intensive care unit
KW - neonatal sepsis
UR - http://www.scopus.com/inward/record.url?scp=85112125005&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85112125005&partnerID=8YFLogxK
U2 - 10.1093/cid/ciaa554
DO - 10.1093/cid/ciaa554
M3 - Article
C2 - 32421763
AN - SCOPUS:85112125005
SN - 1058-4838
VL - 73
SP - 271
EP - 280
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 2
ER -